Autosomal recessive nephrogenic diabetes insipidus caused by an Aquaporin-2 mutation

被引:52
作者
Hochberg, Z
VanLieburg, A
Even, L
Brenner, B
Lanir, N
VanOost, BA
Knoers, NVAM
机构
[1] RAMBAM MED CTR, DEPT HEMATOL, IL-31096 HAIFA, ISRAEL
[2] BNAI ZION MED CTR, DEPT PEDIAT, HAIFA, ISRAEL
[3] UNIV NIJMEGEN HOSP, DEPT PEDIAT, NL-6500 HB NIJMEGEN, NETHERLANDS
[4] UNIV NIJMEGEN HOSP, DEPT HUMAN GENET, NL-6500 HB NIJMEGEN, NETHERLANDS
关键词
D O I
10.1210/jc.82.2.686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasopressin V-2 receptors, expressed from an x-chromosomal gene, are involved in antidiuresis, but also in release of coagulation factor VIII and von Willebrand factor (vWF). The present study describes autosomal recessive nephrogenic diabetes insipidus (NDI) in a large cluster of patients in Israel's Lower-Galilee. Evidence for an intact V-2 receptor was concluded by their normal increase in factor VIII and vWF after desmopressin infusion. Thus, in these patients a defect in the pathway beyond the V-2 receptor was suspected. The recent cloning of the human Aquaporin-2 gene enabled us to test this gene as a candidate for such a postreceptor defect. Direct sequencing of the Aquaporin-2 gene revealed a G298T substitution causing a Gly100Stop nonsense mutation in the third transmembrane region. Because this putative disease-causing mutation was identified in index patients of different families, we suggest that all patients are descendants of a common ancestor. Thus, this new entity is characterized by an autosomal recessive NDI. The differential response of clotting factors and urine osmolality to desmopressin may provide a simple tool for clinical diagnosis of a V-2-postreceptor defect. The early stop-codon of Aquaporin-2 results in complete resistance to vasopressin antidiuretic effect.
引用
收藏
页码:686 / 689
页数:4
相关论文
共 12 条
[1]   FACTOR-VIII-RELATED ANTIGEN - MEASUREMENT BY ENZYME IMMUNOASSAY [J].
BARTLETT, A ;
DORMANDY, KM ;
HAWKEY, CM ;
STABLEFORTH, P ;
VOLLER, A .
BRITISH MEDICAL JOURNAL, 1976, 1 (6016) :994-996
[2]   MOLECULAR-CLONING OF THE RECEPTOR FOR HUMAN ANTIDIURETIC-HORMONE [J].
BIRNBAUMER, M ;
SEIBOLD, A ;
GILBERT, S ;
ISHIDO, M ;
BARBERIS, C ;
ANTARAMIAN, A ;
BRABET, P ;
ROSENTHAL, W .
NATURE, 1992, 357 (6376) :333-335
[3]   NORMAL RESPONSE OF FACTOR-VIII AND VON-WILLEBRAND FACTOR TO 1-DEAMINO-8D-ARGININE VASOPRESSIN IN NEPHROGENIC DIABETES-INSIPIDUS [J].
BRENNER, B ;
SELIGSOHN, U ;
HOCHBERG, Z .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :191-193
[4]   Von willebrand factor antigen and factor XI activity levels as predictors of bleeding tendency in Israeli patients with von willebrand's disease [J].
Brenner, B ;
Steinberg, T ;
Laor, A ;
Tavori, S ;
Tatarsky, I ;
Lanir, N .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1995, 1 (04) :260-264
[5]   REQUIREMENT OF HUMAN RENAL WATER CHANNEL AQUAPORIN-2 FOR VASOPRESSIN-DEPENDENT CONCENTRATION OF URINE [J].
DEEN, PMT ;
VERDIJK, MAJ ;
KNOERS, NVAM ;
WIERINGA, B ;
MONNENS, LAH ;
VANOS, CH ;
VANOOST, BA .
SCIENCE, 1994, 264 (5155) :92-95
[6]   A VARIANT OF NEPHROGENIC DIABETES-INSIPIDUS - V2-RECEPTOR ABNORMALITY RESTRICTED TO THE KIDNEY [J].
KNOERS, N ;
MONNENS, LAH .
EUROPEAN JOURNAL OF PEDIATRICS, 1991, 150 (05) :370-373
[7]  
KORBINSKY NL, 1985, LANCET, V1, P1293
[8]   MECHANISM OF PLASMINOGEN ACTIVATOR AND FACTOR-VIII INCREASE AFTER VASOACTIVE DRUGS [J].
MANNUCCI, PM ;
ABERG, M ;
NILSSON, IM ;
ROBERTSON, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1975, 30 (01) :81-93
[9]   A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS [J].
MILLER, SA ;
DYKES, DD ;
POLESKY, HF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1215-1215
[10]   MUTATIONS IN THE V2 VASOPRESSIN RECEPTOR GENE ARE ASSOCIATED WITH X-LINKED NEPHROGENIC DIABETES-INSIPIDUS [J].
PAN, Y ;
METZENBERG, A ;
DAS, S ;
JING, B ;
GITSCHIER, J .
NATURE GENETICS, 1992, 2 (02) :103-106